Hunter I, Greene S A, MacDonald T M, Morris A D
Department of Child Health, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK.
Arch Dis Child. 2000 Sep;83(3):207-10. doi: 10.1136/adc.83.3.207.
To define the prevalence of hypothyroid disease in children and young people, and describe its aetiology.
We identified all patients on the Medicines Monitoring Unit (MEMO) database in the Tayside region of Scotland who had received two or more prescriptions for thyroxine during the study period (January 1993 to December 1995). Using this as a surrogate marker of hypothyroidism, we calculated the prevalence of hypothyroidism in those aged less than 22 years. Main outcome measures were prevalence of thyroxine prescription, estimated prevalence of hypothyroidism, and aetiology of the hypothyroidism (determined from case records, and biochemistry and immunology databases).
Of 103,500 residents aged less than 22 years, 140 were identified as receiving thyroxine on prescription, giving a population prevalence of 0.135%. The ratio of male to female was 1:2.8. Acquired hypothyroidism was the commonest aetiology found in 73%, 66% of which had an autoimmune basis. The prevalence of congenital hypothyroidism was 0.027%. Seven had received treatment for malignancy (two primary thyroid). Fifteen per cent of patients had no record of secondary care follow up in Tayside.
The overall prevalence of hypothyroidism in young people less than 22 years of age is 0.135%, and in the group aged 11-18 years it is 0.113%; these values are at least twice those of previous estimates. This suggests an increase in autoimmune thyroid disease, similar to the rising prevalence of type 1 diabetes, possibly indicating a rising incidence of autoimmunity in young people.
确定儿童和青少年甲状腺功能减退疾病的患病率,并描述其病因。
我们在苏格兰泰赛德地区的药物监测单位(MEMO)数据库中,识别出在研究期间(1993年1月至1995年12月)接受过两份或更多份甲状腺素处方的所有患者。以此作为甲状腺功能减退的替代指标,我们计算了22岁以下人群中甲状腺功能减退的患病率。主要观察指标为甲状腺素处方的患病率、甲状腺功能减退的估计患病率以及甲状腺功能减退的病因(根据病例记录、生化和免疫数据库确定)。
在103500名22岁以下居民中,有140人被确定接受甲状腺素处方治疗,人群患病率为0.135%。男女比例为1:2.8。获得性甲状腺功能减退是最常见的病因,占73%,其中66%有自身免疫基础。先天性甲状腺功能减退的患病率为0.027%。7人曾接受恶性肿瘤治疗(2例原发性甲状腺肿瘤)。15%的患者在泰赛德地区没有二级护理随访记录。
22岁以下年轻人中甲状腺功能减退的总体患病率为0.135%,11 - 18岁组为0.113%;这些数值至少是先前估计值的两倍。这表明自身免疫性甲状腺疾病有所增加,类似于1型糖尿病患病率的上升,可能意味着年轻人自身免疫性疾病的发病率在上升。